Is CSL Limited the best blue-chip stock for downside protection?

CSL Limited (ASX:CSL) may be the best blue-chip stock to buy. It's certainly defensive… but is now the right time to jump on board?

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

It's always nice to own a few stocks that stubbornly refuse to dip when the market wavers.

In the last month the S&P ASX 200 Index (INDEXASX: XJO) is down 5.8% and the ASX All Ordinaries Index (INDEXASX: XAO) is down 5.7%.

Bank shares, which many seem to judge based on yield alone, have led the falls. For example, Commonwealth Bank of Australia (ASX: CBA) shares are down 6.77% and Westpac Banking Corp (ASX: WBC) is down 9.7%.

However not all stocks are falling. In fact, my favourite steadfast stock for the long-term investor dropped less than 1% over the last month – and it started at an already lofty valuation!

I'm referring of course to CSL Limited (ASX: CSL), a protein science company that collects and fractionates human blood as well as continually developing new treatments. You can read about CSL's products in this article, but today I'd like to focus on two simple charts that demonstrate why the company is one of the best to own in good times and bad. 

CSL Return On Investments

This chart shows the company's return on investments. What it demonstrates is that over time, CSL has been able to reinvest in its own business at incrementally improving rates of return. However, investors should remember that the company has limited reinvestment opportunities, and as a result it has a policy of continually purchasing its own shares on market. Which leads me to the second chart…

Capital Spending Cashflow CSL ASX

This chart shows that cashflow is growing at a faster rate than capital spending, and suggests that much of the company's growth is due to smart allocation of capital, rather than luck. The gap between the two lines is a rough measure of free cash-flow, which is the amount of money the company can spend on paying dividends and buying back shares.

Speaking of which, at current prices the company yields only 1.8%, and it is in part this low yield that has kept me from becoming a shareholder. However, for a long-term investor who wants to minimise the risk of capital loss, CSL is a great company to own because there are many who would love to buy shares on any weakness. The odds are that if shareholders are selling CSL, it's not because they've lost faith in the company, but rather because they see greater value elsewhere.

Because it is in the medical business, CSL should also benefit from the ageing population, and is unlikely to ever suffer a significant drop in demand for its products. Indeed, some of the company's products are required to replace blood lost due to injury, or for life-saving surgery. So although no-one in their right mind would hope for those kind of emergencies, it's easy to understand why I consider CSL a defensive investment.

Motley Fool contributor Claude Walker has no financial interest in any company mentioned.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »